Literature DB >> 10959087

Mechanism and relevance of ploidy in neuroblastoma.

Y Kaneko1, A G Knudson.   

Abstract

Neuroblastoma has a broad spectrum of clinical behavior, ranging from spontaneous regression to dissemination and fatality. The heterogeneity that has long puzzled many investigators has been shown by more recent studies to be closely correlated with various clinical and genetic factors. Tumor cell ploidy is one of the factors; diploid and near-triploid neuroblastomas show poor and excellent clinical outcomes, respectively. We offer a hypothesis that explains how the ploidy state of the tumor plays a fundamental role in this heterogeneity, and why various prognostic factors are correlated with each other. This hypothesis may be applicable to tumors other than neuroblastoma. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10959087     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1021>3.0.co;2-y

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

Review 1.  Cancer chromosomal instability: therapeutic and diagnostic challenges.

Authors:  Nicholas McGranahan; Rebecca A Burrell; David Endesfelder; Marco R Novelli; Charles Swanton
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

Review 2.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

Review 3.  The origins and functions of hepatic polyploidy.

Authors:  Shuyuan Zhang; Yu-Hsuan Lin; Branden Tarlow; Hao Zhu
Journal:  Cell Cycle       Date:  2019-05-26       Impact factor: 4.534

Review 4.  Gene profiling of high risk neuroblastoma.

Authors:  Sanjeev A Vasudevan; Jed G Nuchtern; Jason M Shohet
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

5.  Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.

Authors:  Audrey Rousseau; Ahmed Idbaih; François Ducray; Emmanuelle Crinière; Michèle Fèvre-Montange; Anne Jouvet; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2009-10-29       Impact factor: 4.130

6.  Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox?

Authors:  H J Gilhuis; J van der Laak; P Wesseling; R H Boerman; G Beute; J L M J Teepen; J A Grotenhuis; A C Kappelle
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

7.  Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification.

Authors:  Eiso Hiyama; Hiroaki Yamaoka; Satoshi Kondo; Akihiro Yoneda; Tatsuro Tajiri; Masahiro Fukuzawa; Masahiko Sugiyama; Yutaka Hayashi; Fumiaki Sasaki; Megu Ohtaki
Journal:  Pediatr Surg Int       Date:  2007-08-16       Impact factor: 1.827

8.  Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma.

Authors:  Xiaoying Shang; Susan M Burlingame; M Fatih Okcu; Ningling Ge; Heidi V Russell; Rachel A Egler; Rodney D David; Sanjeev A Vasudevan; Jianhua Yang; Jed G Nuchtern
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

9.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

10.  Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state.

Authors:  Gisela Lundberg; Yuesheng Jin; Daniel Sehic; Ingrid Øra; Rogier Versteeg; David Gisselsson
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.